Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
90.42
+0.18 (0.20%)
At close: May 6, 2026, 4:00 PM EDT
92.00
+1.58 (1.75%)
Pre-market: May 7, 2026, 8:04 AM EDT

Dianthus Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
627.6751.0922.79132.3315.37131.65
Short-Term Investments
483.59353.21252.4541.3960.1345.28
Cash & Short-Term Investments
1,111404.3275.24173.7275.49176.93
Cash Growth
322.16%46.89%58.44%130.12%-57.33%18.87%
Accounts Receivable
1.230.05----
Other Receivables
--0.810.485.64-
Total Trade Receivables
1.230.050.810.485.64-
Other Current Assets
7.425.094.863.260.913.77
Total Current Assets
1,120409.44280.9177.4582.03180.69
Net Property, Plant & Equipment
1.571.631.750.80.967.46
Long-Term Investments
113.87110.1481.73---
Other Long-Term Assets
11.549.729.631.150.121.78
Total Assets
1,247530.92374.01179.4183.11189.93
Accounts Payable
5.279.734.582.611.173.04
Accrued Expenses
31.1319.4513.076.56.617.82
Current Portion of Leases
0.40.370.320.420.35-
Unearned Revenue
1.491.190.480.10.1-
Total Current Liabilities
38.2830.7318.459.638.2310.86
Long-Term Leases
0.971.021.170.170.44-
Other Long-Term Liabilities
6.325.771.910.740.796.4
Total Long-Term Liabilities
7.296.793.080.91.236.4
Total Liabilities
45.5737.5221.5310.549.4517.26
Common Stock
0.050.040.030.02-0.06
Additional Paid-in Capital
1,579829.6526.73258.231.66498.21
Accumulated Other Comprehensive Income
-0.580.490.110.05-0.16-0.03
Retained Earnings
-377.56-336.73-174.39-89.42-45.87-325.57
Total Common Shareholders' Equity
1,201493.4352.48168.87-44.37172.67
Minority Interest
----118.02-
Shareholders' Equity
1,201493.4352.48168.8773.66172.67
Total Liabilities & Equity
1,247530.92374.01179.4183.11189.93
Total Debt
1.361.391.490.590.790
Net Cash (Debt)
1,110402.91273.75173.1374.7176.93
Net Cash Growth
175.47%47.18%58.12%131.76%-57.78%18.87%
Net Cash Per Share
26.6410.438.2233.6085.45202.56
Book Value
1,201493.4352.48168.87-44.37172.67
Book Value Per Share
28.8412.7810.5832.77-50.75197.69
Tangible Book Value
1,201493.4352.48168.87-44.37172.67
Tangible Book Value Per Share
28.8412.7810.5832.77-50.75197.69
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q